Advertisement
U.S. markets closed

Day One Biopharmaceuticals, Inc. (DAWN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
13.72+0.38 (+2.85%)
At close: 04:00PM EST
13.99 +0.27 (+1.97%)
After hours: 07:01PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close13.34
Open13.31
Bid13.67 x 100
Ask13.76 x 100
Day's Range13.28 - 13.91
52 Week Range11.30 - 18.07
Volume591,558
Avg. Volume1,065,545
Market Cap1.384B
Beta (5Y Monthly)-1.52
PE Ratio (TTM)N/A
EPS (TTM)-0.97
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est37.00
  • GlobeNewswire

    Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development

    Dr. Blackman’s departure planned for end of 2024 Company’s search for a new Head of R&D is ongoing BRISBANE, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that Samuel Blackman, M.D., Ph.D, co-founder and Head of Research & Development (R&D) of the Company, will be

  • GlobeNewswire

    Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference

    BRISBANE, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3 at 3:00 p.m. EST. A live webcast of the discussion will be available by visiti